Bleakley Financial Group, LLC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1936953 PARSIPPANY, NJ

Position in BMRN

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$680,460

+$350,890 QoQ

Shares Held

11,892

+137.2% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#311

of 561 holders

Holding Since

Dec 2022

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Bleakley Financial Group, LLC holds $23,738,174 across 21 Biotechnology names. BMRN ranks #9 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	18,400	$9,139,832
2	ANAB	Anaptysbio, Inc	42,761	$2,886,367
3	PTGX	Protagonist Therapeutics, Inc	12,538	$1,536,908
4	IONS	Ionis Pharmaceuticals Inc	14,793	$1,172,936
5	IBRX	ImmunityBio, Inc.	129,381	$1,132,730
6	CORT	Corcept Therapeutics Inc	11,638	$1,011,924
7	BCAX	Bicara Therapeutics Inc.	29,181	$866,383
8	RPRX	Royalty Pharma plc	14,626	$820,079

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$680,460	11,892	+137.2%	Shares	Sole	2026-08-05
2024-12-31	$329,570	5,014	+96.8%	Shares	Sole	2025-01-27
2024-06-30	$209,776	2,548	-13.9%	Shares	Sole	2024-08-12
2024-03-31	$258,351	2,958	-3.4%	Shares	Sole	2024-05-08
2023-12-31	$295,238	3,062	+3.1%	Shares	Sole	2024-01-25
2023-09-30	$262,874	2,971	+8.3%	Shares	Sole	2023-11-14
2023-06-30	$237,763	2,743	+3.1%	Shares	Sole	2023-08-14
2023-03-31	$258,658	2,660	-83.1%	Shares	Sole	2023-05-12
2022-12-31	$1,633,589	15,785	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.